As compared to WT CD8+ T cells, Ezh2−/− CD8+ T cells produced 1.5- to 2-fold more OVA257–264-specific T cells 3 days after infection, maintained at 4 days, and dramatically declined by 5 days (Supplementary Fig. 4a, b). The gene discussed is CD8A; the disease is infection.